Kenya
The Kenyan Government will soon rolled out a drug that will be taken by HIV negative people who are mostly at risk of HIV infection.
The drug, known as Pre-exposure Prophylaxis will be administered daily by those at high risk of contracting the virus before being made accessible to the rest of the Kenyan population.
The drug coats human being’s cells and prevents the HIV virus from attaching to the cells, thus being able to fight off the HIV virus.

This came after a study conducted both in Kenya and Uganda showed that if taken once daily, the drug can prevent HIV infection by more than one percent.
If used consistently, the drug can significantly reduce the risk of getting HIV from unprotected sex.
Kenya is the second country after South Africa to roll out the program said to reduce the risk of HIV infection in people who are at high risk by up to 92 per cent if taken consistently.
Go to video
AI-generated Africa map blunder overshadows U.S. presentation at global AIDS conference
01:47
Funding cuts threaten Africa's progress in fight against disease
Go to video
U.S. funding cuts have gutted global AIDS program, report finds
Go to video
UNAids warns US funding cut could cost lives in South Africa
01:39
Ramaphosa hails Lenacapavir roll out as turning point in HIV fight
00:58
Former Botswana president Festus Mogae dies at 86